Pristinamycin in the treatment of MSSA bone and joint infection.
Valour F, Boibieux A, Karsenty J, Vallat MP, Braun E, Perpoint T, Biron F, Laurent F, Lustig S, Chidiac C, Ferry T; Lyon Bone and Joint Infection Study Group.
Valour F, et al.
J Antimicrob Chemother. 2016 Apr;71(4):1063-70. doi: 10.1093/jac/dkv457. Epub 2016 Jan 21.
J Antimicrob Chemother. 2016.
PMID: 26801082
OBJECTIVES: The aim of this study was to evaluate pristinamycin in the treatment of MSSA bone and joint infection (BJI). PATIENTS AND METHODS: A retrospective, single-centre cohort study (2001-11) investigated outcome in adults receiving pristinamycin for MSSA BJI and pris …
OBJECTIVES: The aim of this study was to evaluate pristinamycin in the treatment of MSSA bone and joint infection (BJI). PATIENTS AND …